Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Facial paresis
ADR ID BADD_A05019
ADR Hierarchy
17      Nervous system disorders
17.04      Cranial nerve disorders (excl neoplasms)
17.04.03      Facial cranial nerve disorders
17.04.03.002      Facial paresis
Description Severe or complete loss of facial muscle motor function. This condition may result from central or peripheral lesions. Damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles. FACIAL NERVE DISEASES generally results in generalized hemifacial weakness. NEUROMUSCULAR JUNCTION DISEASES and MUSCULAR DISEASES may also cause facial paralysis or paresis. [MeSH]
MedDRA Code 10051267
MeSH ID D005158
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Facial paresis | Facial weakness | Facial muscle weakness | Facial nerve paresis | Facial Paralysis | Paralyses, Facial | Paralysis, Facial | Facial Palsy | Facial Palsies | Palsies, Facial | Palsy, Facial | Hemifacial Paralysis | Paralyses, Hemifacial | Paralysis, Hemifacial | Facial Paresis | Pareses, Facial | Paresis, Facial | Facial Palsy, Lower Motor Neuron | Lower Motor Neuron Facial Palsy | Facial Paralysis, Peripheral | Facial Paralyses, Peripheral | Paralysis, Peripheral Facial | Peripheral Facial Paralysis | Facial Palsy, Upper Motor Neuron | Upper Motor Neuron Facial Palsy | Facial Paralysis, Central | Central Facial Paralyses | Central Facial Paralysis | Facial Paralyses, Central | Paralyses, Central Facial | Paralysis, Central Facial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000066%
BADD_D00151Apixaban0.000195%
BADD_D00195Azathioprine0.000313%
BADD_D00290Botulinum toxin type a--
BADD_D00308Bupivacaine--
BADD_D00347Candesartan cilexetil0.000841%
BADD_D00415Cerivastatin--
BADD_D00474Cisplatin0.000168%
BADD_D00504Clopidogrel0.000053%
BADD_D00563Dabigatran0.001468%
BADD_D00609Deoxycholic acid0.014257%
BADD_D00723Doxorubicin0.000112%
BADD_D00809Escitalopram--
BADD_D00932Fluoxetine0.000069%
BADD_D00948Fluvastatin--
BADD_D01119Ibrutinib0.000168%
BADD_D01236Labetalol0.000325%
BADD_D01325Lovastatin--
BADD_D01470Minocycline0.000118%
BADD_D01567Nilotinib0.000336%
BADD_D01599Olanzapine0.000210%
BADD_D01616Onabotulinumtoxina--
BADD_D01653Paclitaxel0.000280%
BADD_D01824Pravastatin--
BADD_D01825Pravastatin sodium--
BADD_D01831Prednisolone0.000035%
BADD_D01834Prednisone0.000022%
BADD_D01835Pregabalin0.000130%
BADD_D01924Repaglinide0.001113%
BADD_D01951Risperidone0.000364%
The 1th Page    1 2    Next   Last    Total 2 Pages